H 2217
An Act relative to opioid reversal drugs
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill aims to increase access to and awareness of opioid reversal drugs, specifically naloxone, to combat the opioid crisis in Massachusetts. It seeks to expand the availability of these medications and educate the public on how to use them effectively in the event of an opioid overdose. The bill also supports ongoing research and data collection related to opioid overdoses and their prevention. Ultimately, the goal is to reduce the number of opioid-related deaths.
Key provisions
- Expands access to naloxone by encouraging its distribution through various channels.
- Requires the Department of Public Health to develop and implement a public awareness campaign about naloxone.
- Supports training programs for first responders and community members on how to administer naloxone.
- Directs the Department of Public Health to study the effectiveness of naloxone distribution programs.
- Promotes collaboration between healthcare providers and community organizations to increase naloxone availability.
Who is affected
- Individuals at risk of opioid overdose
- First responders (police, firefighters, EMTs)
- Healthcare providers
- Community organizations
- The general public
Notable changes
- Increases public awareness of naloxone and its use.
- Expands access to naloxone beyond traditional healthcare settings.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Sally P. Kerans
Cosponsor
Sally P. Kerans
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.
Bill H.2217 194th (Current)
An Act relative to opioid reversal drugs
By Representative Kerans of Danvers, a petition (accompanied by bill, House, No. 2217) of Sally P. Kerans relative to opioid reversal drugs. Mental Health, Substance Use and Recovery.
View Text Print Preview Download PDF
Bill Information
Bill Information
Presenter: Sally P. Kerans
Tabs
Bill History Petitioners Committee Vote Committee Summary Hearing Attendance
Bill History
Displaying 5 actions for Bill H.2217
| Date | Branch | Action |
| 2/27/2025 | House | Referred to the committee on Mental Health, Substance Use and Recovery |
| 2/27/2025 | Senate | Senate concurred |
| 10/24/2025 | Joint | Hearing scheduled for 11/03/2025 from 01:00 PM-05:00 PM in A-2 |
| House | Reported by committee to Clerk’s Office for processing, will accompany a study order | |
| 3/30/2026 | House | Accompanied a study order, see H5319 (under House Rule 27) |
Similar Bills
H.2212 194th (Current)
An Act relative to patient opioid notification
H.2230 194th (Current)
An Act relative to overdose mapping
S.1418 194th (Current)
An Act relative to fetal opioid drug exposure
S.382 194th (Current)
An Act requiring opioid use disorder education
S.413 194th (Current)
An Act to save lives through increased fentanyl awareness, aka Andrew's Law
The information contained in this website is for general information purposes only. The General Court provides this information as a public service and while we endeavor to keep the data accurate and current to the best of our ability, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.